{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:28Z","timestamp":1792097308010,"version":"4.4.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41581-026-01111-y","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:01:51Z","timestamp":1790697711000},"page":"765-783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic control by liver\u2013kidney crosstalk and glucagon in health and disease"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-2063","authenticated-orcid":false,"given":"Volker","family":"Vallon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-5753","authenticated-orcid":false,"given":"Nicolai J.","family":"Wewer Albrechtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"1111_CR1","doi-asserted-by":"publisher","first-page":"7309","DOI":"10.1074\/jbc.R700042200","volume":"283","author":"MB Burg","year":"2008","unstructured":"Burg, M. B. & Ferraris, J. D. Intracellular organic osmolytes: function and regulation. J. Biol. Chem. 283, 7309\u20137313 (2008).","journal-title":"J. Biol. Chem."},{"key":"1111_CR2","first-page":"E409","volume":"276","author":"K Zierler","year":"1999","unstructured":"Zierler, K. Whole body glucose metabolism. Am. J. Physiol. 276, E409\u2013E426 (1999).","journal-title":"Am. J. Physiol."},{"key":"1111_CR3","doi-asserted-by":"publisher","first-page":"E859","DOI":"10.1152\/ajpendo.00165.2014","volume":"307","author":"GM Kowalski","year":"2014","unstructured":"Kowalski, G. M. & Bruce, C. R. The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents. Am. J. Physiol. Endocrinol. Metab. 307, E859\u2013E871 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1111_CR4","first-page":"E1209","volume":"273","author":"V Chandramouli","year":"1997","unstructured":"Chandramouli, V. et al. Quantifying gluconeogenesis during fasting. Am. J. Physiol. 273, E1209\u2013E1215 (1997).","journal-title":"Am. J. Physiol."},{"key":"1111_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1172\/JCI118803","volume":"98","author":"BR Landau","year":"1996","unstructured":"Landau, B. R. et al. Contributions of gluconeogenesis to glucose production in the fasted state. J. Clin. Invest. 98, 378\u2013385 (1996).","journal-title":"J. Clin. Invest."},{"key":"1111_CR6","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1007\/s00125-023-05947-y","volume":"66","author":"NJ Wewer Albrechtsen","year":"2023","unstructured":"Wewer Albrechtsen, N. J. et al. 100 years of glucagon and 100 more. Diabetologia 66, 1378\u20131394 (2023).","journal-title":"Diabetologia"},{"key":"1111_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41586-020-2074-6","volume":"579","author":"RJ Perry","year":"2020","unstructured":"Perry, R. J. et al. Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis. Nature 579, 279\u2013283 (2020).","journal-title":"Nature"},{"key":"1111_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133314","volume":"20","author":"L Janah","year":"2019","unstructured":"Janah, L. et al. Glucagon receptor signaling and glucagon resistance. Int. J. Mol. Sci. 20, 3314 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1111_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115074","volume":"201","author":"CC Paulusma","year":"2022","unstructured":"Paulusma, C. C., Lamers, W. H., Broer, S. & van de Graaf, S. F. J. Amino acid metabolism, transport and signalling in the liver revisited. Biochem. Pharmacol. 201, 115074 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"1111_CR10","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1002\/j.2040-4603.2022.tb00207.x","volume":"12","author":"V Vallon","year":"2021","unstructured":"Vallon, V. & Nakagawa, T. Renal tubular handling of glucose and fructose in health and disease. Compr. Physiol. 12, 2995\u20133044 (2021).","journal-title":"Compr. Physiol."},{"key":"1111_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1464-5491.2009.02894.x","volume":"27","author":"JE Gerich","year":"2010","unstructured":"Gerich, J. E. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet. Med. 27, 136\u2013142 (2010).","journal-title":"Diabet. Med."},{"key":"1111_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/ki.1976.26","volume":"9","author":"U Schmidt","year":"1976","unstructured":"Schmidt, U. & Guder, W. G. Sites of enzyme activity along the nephron. Kidney Int. 9, 233\u2013242 (1976).","journal-title":"Kidney Int."},{"key":"1111_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1042\/bj1640185","volume":"164","author":"RA Iles","year":"1977","unstructured":"Iles, R. A., Cohen, R. D., Rist, A. H. & Baron, P. G. The mechanism of inhibition by acidosis of gluconeogenesis from lactate in rat liver. Biochem. J. 164, 185\u2013191 (1977).","journal-title":"Biochem. J."},{"key":"1111_CR14","first-page":"F246","volume":"235","author":"HB Burch","year":"1978","unstructured":"Burch, H. B. et al. Distribution along the rat nephron of three enzymes of gluconeogenesis in acidosis and starvation. Am. J. Physiol. 235, F246\u2013F253 (1978).","journal-title":"Am. J. Physiol."},{"key":"1111_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ki.1984.143","volume":"26","author":"WG Guder","year":"1984","unstructured":"Guder, W. G. & Ross, B. D. Enzyme distribution along the nephron. Kidney Int. 26, 101\u2013111 (1984).","journal-title":"Kidney Int."},{"key":"1111_CR16","first-page":"3","volume":"53","author":"KD Drewnowsk","year":"2002","unstructured":"Drewnowsk, K. D. et al. PEPCK mRNA localization in proximal tubule and gene regulation during metabolic acidosis. J. Physiol. Pharmacol. 53, 3\u201320 (2002).","journal-title":"J. Physiol. Pharmacol."},{"key":"1111_CR17","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.2337\/db11-0571","volume":"60","author":"E Mutel","year":"2011","unstructured":"Mutel, E. et al. Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon. Diabetes 60, 3121\u20133131 (2011).","journal-title":"Diabetes"},{"key":"1111_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2023.12.024","volume":"36","author":"MY Wang","year":"2024","unstructured":"Wang, M. Y. et al. Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease. Cell Metab. 36, 575\u2013597.e7 (2024).","journal-title":"Cell Metab."},{"key":"1111_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2337\/diacare.24.2.382","volume":"24","author":"JE Gerich","year":"2001","unstructured":"Gerich, J. E., Meyer, C., Woerle, H. J. & Stumvoll, M. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24, 382\u2013391 (2001).","journal-title":"Diabetes Care"},{"key":"1111_CR20","doi-asserted-by":"publisher","first-page":"F1195","DOI":"10.1152\/ajprenal.00133.2005","volume":"289","author":"E Sohara","year":"2005","unstructured":"Sohara, E. et al. Defective water and glycerol transport in the proximal tubules of AQP7 knockout mice. Am. J. Physiol. Renal Physiol. 289, F1195\u2013F1200 (2005).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1111_CR21","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/j.2040-4603.2013.tb00533.x","volume":"3","author":"AP Halestrap","year":"2013","unstructured":"Halestrap, A. P. Monocarboxylic acid transport. Compr. Physiol. 3, 1611\u20131643 (2013).","journal-title":"Compr. Physiol."},{"key":"1111_CR22","doi-asserted-by":"publisher","first-page":"F141","DOI":"10.1152\/ajprenal.00488.2009","volume":"299","author":"HM Becker","year":"2010","unstructured":"Becker, H. M. et al. Localization of members of MCT monocarboxylate transporter family Slc16 in the kidney and regulation during metabolic acidosis. Am. J. Physiol. Renal Physiol 299, F141\u2013F154 (2010).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR23","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/ki.2012.67","volume":"81","author":"L Bankir","year":"2012","unstructured":"Bankir, L. & Yang, B. New insights into urea and glucose handling by the kidney, and the urine concentrating mechanism. Kidney Int. 81, 1179\u20131198 (2012).","journal-title":"Kidney Int."},{"key":"1111_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molmet.2019.11.005","volume":"31","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Kwon, H., Su, X. & Wondisford, F. E. Glycerol not lactate is the major net carbon source for gluconeogenesis in mice during both short and prolonged fasting. Mol. Metab. 31, 36\u201344 (2020).","journal-title":"Mol. Metab."},{"key":"1111_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102708","volume":"298","author":"H Xu","year":"2022","unstructured":"Xu, H. et al. Glucagon changes substrate preference in gluconeogenesis. J. Biol. Chem. 298, 102708 (2022).","journal-title":"J. Biol. Chem."},{"key":"1111_CR26","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/ndt\/gfae060","volume":"39","author":"V Vallon","year":"2024","unstructured":"Vallon, V. How can inhibition of glucose and sodium transport in the early proximal tubule protect the cardiorenal system? Nephrol. Dial. Transplant. 39, 1565\u20131573 (2024).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1111_CR27","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.2337\/db16-1602","volume":"66","author":"M Sasaki","year":"2017","unstructured":"Sasaki, M. et al. Dual regulation of gluconeogenesis by insulin and glucose in the proximal tubules of the kidney. Diabetes 66, 2339\u20132350 (2017).","journal-title":"Diabetes"},{"key":"1111_CR28","doi-asserted-by":"publisher","first-page":"F419","DOI":"10.1152\/ajprenal.00497.2018","volume":"317","author":"A Onishi","year":"2019","unstructured":"Onishi, A. et al. Effect of renal tubule-specific knockdown of the Na+\/H+ exchanger NHE3 in Akita diabetic mice. Am. J. Physiol. Renal Physiol 317, F419\u2013F434 (2019).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR29","doi-asserted-by":"publisher","first-page":"F194","DOI":"10.1152\/ajprenal.00520.2013","volume":"306","author":"V Vallon","year":"2014","unstructured":"Vallon, V. et al. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Am. J. Physiol. Renal Physiol 306, F194\u2013F204 (2014).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.nutr.22.110801.140547","volume":"22","author":"SM Morris","year":"2002","unstructured":"Morris, S. M. Regulation of enzymes of the urea cycle and arginine metabolism. Annu. Rev. Nutr. 22, 87\u2013105 (2002).","journal-title":"Annu. Rev. Nutr."},{"key":"1111_CR31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0968-0004(84)90293-7","volume":"9","author":"DE Atkinson","year":"1984","unstructured":"Atkinson, D. E. & Bourke, E. The role of ureagenesis in pH homeostasis. Trends Biochem. Sci. 9, 297\u2013300 (1984).","journal-title":"Trends Biochem. Sci."},{"key":"1111_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/bj2670281","volume":"267","author":"D Ha\u00fcssinger","year":"1990","unstructured":"Ha\u00fcssinger, D. Nitrogen metabolism in liver: structural and functional organization and physiological relevance. Biochem. J. 267, 281\u2013290 (1990).","journal-title":"Biochem. J."},{"key":"1111_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100675","volume":"27","author":"P Katopodis","year":"2022","unstructured":"Katopodis, P., Pappas, E. M. & Katopodis, K. P. Acid-base abnormalities and liver dysfunction. Ann. Hepatol. 27, 100675 (2022).","journal-title":"Ann. Hepatol."},{"key":"1111_CR34","doi-asserted-by":"publisher","first-page":"2494S","DOI":"10.1093\/jn\/nxaa094","volume":"150","author":"MH Stipanuk","year":"2020","unstructured":"Stipanuk, M. H. Metabolism of sulfur-containing amino acids: how the body copes with excess methionine, cysteine, and sulfide. J. Nutr. 150, 2494S\u20132505S (2020).","journal-title":"J. Nutr."},{"key":"1111_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/BF00235522","volume":"70","author":"D H\u00e4ussinger","year":"1992","unstructured":"H\u00e4ussinger, D., Steeb, R. & Gerok, W. Metabolic alkalosis as driving force for urea synthesis in liver disease: pathogenetic model and therapeutic implications. Clin. Investig. 70, 411\u2013415 (1992).","journal-title":"Clin. Investig."},{"key":"1111_CR36","unstructured":"Atkinson, D. E., Bourke, E. Heisler, N. (ed). in Mechanisms of Systemic Regulation: Acid-Base Regulation, Ion-Transfer and Metabolism. (Springer, 1995)."},{"key":"1111_CR37","first-page":"237","volume":"18","author":"MK Almond","year":"1992","unstructured":"Almond, M. K., Iles, R. A. & Cohen, R. D. Hepatic glutamine metabolism and acid-base regulation. Min. Electrolyte Metab. 18, 237\u2013240 (1992).","journal-title":"Min. Electrolyte Metab."},{"key":"1111_CR38","doi-asserted-by":"publisher","first-page":"G1145","DOI":"10.1152\/ajpgi.1999.276.5.G1145","volume":"276","author":"RE Shangraw","year":"1999","unstructured":"Shangraw, R. E. & Jahoor, F. Effect of liver disease and transplantation on urea synthesis in humans: relationship to acid-base status. Am. J. Physiol. Gastrointest. Liver Physiol. 276, G1145\u2013G1152 (1999).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1111_CR39","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.semnephrol.2006.11.001","volume":"26","author":"SN Ahya","year":"2006","unstructured":"Ahya, S. N., Jos\u00e9 Soler, M., Levitsky, J. & Batlle, D. Acid-base and potassium disorders in liver disease. Semin. Nephrol. 26, 466\u2013470 (2006).","journal-title":"Semin. Nephrol."},{"key":"1111_CR40","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.2215\/CJN.10311013","volume":"10","author":"ID Weiner","year":"2015","unstructured":"Weiner, I. D., Mitch, W. E. & Sands, J. M. Urea and ammonia metabolism and the control of renal nitrogen excretion. Clin. J. Am. Soc. Nephrol. 10, 1444\u20131458 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1111_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1152\/physrev.00011.2016","volume":"97","author":"ID Weiner","year":"2017","unstructured":"Weiner, I. D. & Verlander, J. W. Ammonia transporters and their role in acid-base balance. Physiol. Rev. 97, 465\u2013494 (2017).","journal-title":"Physiol. Rev."},{"key":"1111_CR42","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1681\/ASN.2004060433","volume":"16","author":"TT Solbu","year":"2005","unstructured":"Solbu, T. T. et al. Induction and targeting of the glutamine transporter SN1 to the basolateral membranes of cortical kidney tubule cells during chronic metabolic acidosis suggest a role in pH regulation. J. Am. Soc. Nephrol. 16, 869\u2013877 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR43","doi-asserted-by":"publisher","first-page":"F752","DOI":"10.1152\/ajprenal.00044.2025","volume":"328","author":"HW Lee","year":"2025","unstructured":"Lee, H. W., Harris, A. N., Hyndman, K. A. & Weiner, I. D. Lack of a role of NHE4 in renal ammonia metabolism. Am. J. Physiol. Renal Physiol 328, F752\u2013F765 (2025).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR44","doi-asserted-by":"publisher","first-page":"F366","DOI":"10.1152\/ajprenal.00501.2019","volume":"319","author":"P Alam","year":"2020","unstructured":"Alam, P., Amlal, S., Thakar, C. V. & Amlal, H. Acetazolamide causes renal HCO3\u2212 wasting but inhibits ammoniagenesis and prevents the correction of metabolic acidosis by the kidney. Am. J. Physiol. Renal Physiol. 319, F366\u2013F379 (2020).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1111_CR45","doi-asserted-by":"publisher","first-page":"8510","DOI":"10.1096\/fj.202000273R","volume":"34","author":"S Ghazi","year":"2020","unstructured":"Ghazi, S. et al. Multiparametric imaging reveals that mitochondria-rich intercalated cells in the kidney collecting duct have a very high glycolytic capacity. FASEB J. 34, 8510\u20138525 (2020).","journal-title":"FASEB J."},{"key":"1111_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-024-01437-1","volume":"40","author":"H Vilstrup","year":"2024","unstructured":"Vilstrup, H. et al. Down the road towards hepatic encephalopathy. Urea synthesis \u2014 the liver workhorse of nitrogen metabolism. Metab. Brain Dis. 40, 49 (2024).","journal-title":"Metab. Brain Dis."},{"key":"1111_CR47","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1172\/JCI88532","volume":"127","author":"K Kitada","year":"2017","unstructured":"Kitada, K. et al. High salt intake reprioritizes osmolyte and energy metabolism for body fluid conservation. J. Clin. Invest. 127, 1944\u20131959 (2017).","journal-title":"J. Clin. Invest."},{"key":"1111_CR48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1681\/ASN.2006101108","volume":"18","author":"RA Fenton","year":"2007","unstructured":"Fenton, R. A. & Knepper, M. A. Urea and renal function in the 21st century: insights from knockout mice. J. Am. Soc. Nephrol. 18, 679\u2013688 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1054\/clnu.2001.0476","volume":"20","author":"O Hamberg","year":"2001","unstructured":"Hamberg, O., Andersen, V., Sonne, J., Larsen, S. & Vilstrup, H. Urea synthesis in patients with chronic pancreatitis: relation to glucagon secretion and dietary protein intake. Clin. Nutr. 20, 493\u2013501 (2001).","journal-title":"Clin. Nutr."},{"key":"1111_CR50","doi-asserted-by":"crossref","unstructured":"Depner, T. A. in Prescribing Hemodialysis: A Guide to Urea Modeling. 25\u201337 (Springer, 1991).","DOI":"10.1007\/978-1-4613-1509-4_2"},{"key":"1111_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1432-1033.1985.tb08824.x","volume":"148","author":"AJ Meijer","year":"1985","unstructured":"Meijer, A. J., Lof, C., Ramos, I. C. & Verhoeven, A. J. Control of ureogenesis. Eur. J. Biochem. 148, 189\u2013196 (1985).","journal-title":"Eur. J. Biochem."},{"key":"1111_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105296","volume":"25","author":"E Elmelund","year":"2022","unstructured":"Elmelund, E. et al. Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells. iScience 25, 105296 (2022).","journal-title":"iScience"},{"key":"1111_CR53","first-page":"796","volume":"148","author":"L Bankir","year":"2024","unstructured":"Bankir, L., Crambert, G. & Vargas-Poussou, R. The SLC6A18 transporter is most likely a Na-dependent glycine\/urea antiporter responsible for urea secretion in the proximal straight tubule: influence of this urea secretion on glomerular filtration rate. Nephron 148, 796\u2013822 (2024).","journal-title":"Nephron"},{"key":"1111_CR54","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/j.2040-4603.2011.tb00342.x","volume":"1","author":"JD Klein","year":"2011","unstructured":"Klein, J. D., Blount, M. A. & Sands, J. M. Urea transport in the kidney. Compr. Physiol. 1, 699\u2013729 (2011).","journal-title":"Compr. Physiol."},{"key":"1111_CR55","doi-asserted-by":"publisher","first-page":"F1271","DOI":"10.1152\/ajprenal.90252.2008","volume":"295","author":"TL Pannabecker","year":"2008","unstructured":"Pannabecker, T. L., Dantzler, W. H., Layton, H. E. & Layton, A. T. Role of three-dimensional architecture in the urine concentrating mechanism of the rat renal inner medulla. Am. J. Physiol. Renal Physiol 295, F1271\u2013F1285 (2008).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1152\/ajplegacy.1934.109.1.139","volume":"109","author":"JLMCF Gamble","year":"1934","unstructured":"Gamble, J. L. M. C. F., Butler, A. M. & Tuthill, E. An economy of water in renal function referable to urea. Am. J. Physiol. 109, 139\u2013154 (1934).","journal-title":"Am. J. Physiol."},{"key":"1111_CR57","doi-asserted-by":"publisher","first-page":"C195","DOI":"10.1152\/ajpcell.1984.246.3.C195","volume":"246","author":"RI Macey","year":"1984","unstructured":"Macey, R. I. Transport of water and urea in red blood cells. Am. J. Physiol. 246, C195\u2013C203 (1984).","journal-title":"Am. J. Physiol."},{"key":"1111_CR58","first-page":"373","volume":"22","author":"R Burcelin","year":"1996","unstructured":"Burcelin, R., Katz, E. B. & Charron, M. J. Molecular and cellular aspects of the glucagon receptor: role in diabetes and metabolism. Diabetes Metab. 22, 373\u2013396 (1996).","journal-title":"Diabetes Metab."},{"key":"1111_CR59","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2337\/diab.33.4.328","volume":"33","author":"E Beale","year":"1984","unstructured":"Beale, E., Andreone, T., Koch, S., Granner, M. & Granner, D. Insulin and glucagon regulate cytosolic phosphoenolpyruvate carboxykinase (GTP) mRNA in rat liver. Diabetes 33, 328\u2013332 (1984).","journal-title":"Diabetes"},{"key":"1111_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/35093050","volume":"413","author":"JC Yoon","year":"2001","unstructured":"Yoon, J. C. et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131\u2013138 (2001).","journal-title":"Nature"},{"key":"1111_CR61","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s00424-003-1117-9","volume":"447","author":"B Mackenzie","year":"2004","unstructured":"Mackenzie, B. & Erickson, J. D. Sodium-coupled neutral amino acid (System N\/A) transporters of the SLC38 gene family. Pflugers Arch. 447, 784\u2013795 (2004).","journal-title":"Pflugers Arch."},{"key":"1111_CR62","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.2337\/dbi22-0004","volume":"71","author":"MM Richter","year":"2022","unstructured":"Richter, M. M. et al. The liver-\u03b1-cell axis in health and in disease. Diabetes 71, 1852\u20131861 (2022).","journal-title":"Diabetes"},{"key":"1111_CR63","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diabres.2018.10.004","volume":"146","author":"L Bankir","year":"2018","unstructured":"Bankir, L., Bouby, N., Speth, R. C., Velho, G. & Crambert, G. Glucagon revisited: coordinated actions on the liver and kidney. Diabetes Res. Clin. Pract. 146, 119\u2013129 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1111_CR64","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/BF00585347","volume":"404","author":"D Butlen","year":"1985","unstructured":"Butlen, D. & Morel, F. Glucagon receptors along the nephron: [125I]glucagon binding in rat tubules. Pflugers Arch. 404, 348\u2013353 (1985).","journal-title":"Pflugers Arch."},{"key":"1111_CR65","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1681\/ASN.2020101406","volume":"32","author":"L Chen","year":"2021","unstructured":"Chen, L., Chou, C. L. & Knepper, M. A. A comprehensive map of mRNAs and their isoforms across all 14 renal tubule segments of mouse. J. Am. Soc. Nephrol. 32, 897\u2013912 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR66","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1681\/ASN.2014111067","volume":"26","author":"JW Lee","year":"2015","unstructured":"Lee, J. W., Chou, C. L. & Knepper, M. A. Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes. J. Am. Soc. Nephrol. 26, 2669\u20132677 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR67","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020010071","author":"K Limbutara","year":"2020","unstructured":"Limbutara, K., Chou, C. L. & Knepper, M. A. Quantitative proteomics of all 14 renal tubule segments in rat. J. Am. Soc. Nephrol. https:\/\/doi.org\/10.1681\/ASN.2020010071 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/cs1040253","volume":"104","author":"J Marks","year":"2003","unstructured":"Marks, J., Debnam, E. S., Dashwood, M. R., Srai, S. K. & Unwin, R. J. Detection of glucagon receptor mRNA in the rat proximal tubule: potential role for glucagon in the control of renal glucose transport. Clin. Sci. 104, 253\u2013258 (2003).","journal-title":"Clin. Sci."},{"key":"1111_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65402-x","volume":"16","author":"X Pan","year":"2025","unstructured":"Pan, X. et al. Fasting hijacks proximal tubule circadian control mechanisms to regulate glucose reabsorption via the Nrf1\/Sglt2 pathway in mice. Nat. Commun. 16, 10447 (2025).","journal-title":"Nat. Commun."},{"key":"1111_CR70","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ki.1972.74","volume":"2","author":"M Levy","year":"1972","unstructured":"Levy, M. & Starr, N. L. The mechanism of glucagon-induced natriuresis in dogs. Kidney Int. 2, 76\u201384 (1972).","journal-title":"Kidney Int."},{"key":"1111_CR71","doi-asserted-by":"crossref","first-page":"F61","DOI":"10.1152\/ajpcell.1977.233.3.C61","volume":"233","author":"J Johannesen","year":"1977","unstructured":"Johannesen, J., Lie, M. & Kiil, F. Effect of glycine and glucagon on glomerular filtration and renal metabolic rates. Am. J. Physiol. 233, F61\u2013F66 (1977).","journal-title":"Am. J. Physiol."},{"key":"1111_CR72","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/0026-0495(67)90047-9","volume":"16","author":"TN Pullman","year":"1967","unstructured":"Pullman, T. N., Lavender, A. R. & Aho, I. Direct effects of glucagon on renal hemodynamics and excretion of inorganic ions. Metabolism 16, 358\u2013373 (1967).","journal-title":"Metabolism"},{"key":"1111_CR73","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1113\/eph8802592","volume":"88","author":"N Denis","year":"2003","unstructured":"Denis, N., Tebot, I., Bonnet, J. M., Cirio, A. & Boivin, R. Effects of intravenous perfusion of glucagon on renal blood flow in conscious sheep. Exp. Physiol. 88, 575\u2013580 (2003).","journal-title":"Exp. Physiol."},{"key":"1111_CR74","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0014-2999(77)90210-2","volume":"41","author":"J Ueda","year":"1977","unstructured":"Ueda, J., Nakanishi, H., Miyazaki, M. & Abe, Y. Effects of glucagon on the renal hemodynamics of dogs. Eur. J. Pharmacol. 41, 209\u2013212 (1977).","journal-title":"Eur. J. Pharmacol."},{"key":"1111_CR75","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF01223273","volume":"13","author":"HH Parving","year":"1977","unstructured":"Parving, H. H. et al. The effect of short-term glucagon infusion on kidney function in normal man. Diabetologia 13, 323\u2013325 (1977).","journal-title":"Diabetologia"},{"key":"1111_CR76","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1172\/JCI111732","volume":"75","author":"FD Seney Jr.","year":"1985","unstructured":"Seney, F. D. Jr. & Wright, F. S. Dietary protein suppresses feedback control of glomerular filtration in rats. J. Clin. Invest. 75, 558\u2013568 (1985).","journal-title":"J. Clin. Invest."},{"key":"1111_CR77","first-page":"F83","volume":"252","author":"FD Seney Jr.","year":"1987","unstructured":"Seney, F. D. Jr., Persson, E. G. & Wright, F. S. Modification of tubuloglomerular feedback signal by dietary protein. Am. J. Physiol. 252, F83\u2013F90 (1987).","journal-title":"Am. J. Physiol."},{"key":"1111_CR78","doi-asserted-by":"publisher","DOI":"10.2337\/db24-319-OR","volume":"73","author":"GC Gyarmati","year":"2024","unstructured":"Gyarmati, G. C. et al. Renoprotective effects of glucagon and incretin agonist combinations mediated by macula densa cells. Diabetes 73, 319-OR (2024).","journal-title":"Diabetes"},{"key":"1111_CR79","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/HYPERTENSIONAHA.119.13077","volume":"74","author":"J Wei","year":"2019","unstructured":"Wei, J. et al. High-protein diet-induced glomerular hyperfiltration is dependent on neuronal nitric oxide synthase \u03b2 in the macula densa via tubuloglomerular feedback response. Hypertension 74, 864\u2013871 (2019).","journal-title":"Hypertension"},{"key":"1111_CR80","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/BF00370791","volume":"419","author":"C de Rouffignac","year":"1991","unstructured":"de Rouffignac, C., Elalouf, J. M. & Roinel, N. Glucagon inhibits water and NaCl transports in the proximal convoluted tubule of the rat kidney. Pflugers Arch. 419, 472\u2013477 (1991).","journal-title":"Pflugers Arch."},{"key":"1111_CR81","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.2215\/CJN.04480413","volume":"9","author":"DB Mount","year":"2014","unstructured":"Mount, D. B. Thick ascending limb of the loop of Henle. Clin. J. Am. Soc. Nephrol. 9, 1974\u20131986 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1111_CR82","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.2023.38.S1.5732351","volume":"38","author":"SBS Poulsen","year":"2023","unstructured":"Poulsen, S. B. S. et al. Glucagon activates NCC in a glucagon receptor-dependent manner. Physiology 38, 5732351 (2023).","journal-title":"Physiology"},{"key":"1111_CR83","doi-asserted-by":"publisher","first-page":"F54","DOI":"10.1152\/ajprenal.90367.2008","volume":"296","author":"Y Yano","year":"2009","unstructured":"Yano, Y. et al. Aquaporin 2 expression increased by glucagon in normal rat inner medullary collecting ducts. Am. J. Physiol. Renal Physiol 296, F54\u2013F59 (2009).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR84","doi-asserted-by":"publisher","first-page":"F2","DOI":"10.1152\/ajprenal.00614.2014","volume":"309","author":"L Bankir","year":"2015","unstructured":"Bankir, L., Roussel, R. & Bouby, N. Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea. Am. J. Physiol. Renal Physiol 309, F2\u2013F23 (2015).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4028","volume":"32","author":"H Qi","year":"2019","unstructured":"Qi, H. et al. Glucagon infusion alters the hyperpolarized 13C-urea renal hemodynamic signature. NMR Biomed. 32, e4028 (2019).","journal-title":"NMR Biomed."},{"key":"1111_CR86","doi-asserted-by":"crossref","first-page":"F24","DOI":"10.1152\/ajpcell.1992.263.1.C24","volume":"263","author":"M Ahloulay","year":"1992","unstructured":"Ahloulay, M. et al. Effects of glucagon on glomerular filtration rate and urea and water excretion. Am. J. Physiol. 263, F24\u2013F36 (1992).","journal-title":"Am. J. Physiol."},{"key":"1111_CR87","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1172\/JCI1420","volume":"101","author":"A Kato","year":"1998","unstructured":"Kato, A. & Sands, J. M. Evidence for sodium-dependent active urea secretion in the deepest subsegment of the rat inner medullary collecting duct. J. Clin. Invest. 101, 423\u2013428 (1998).","journal-title":"J. Clin. Invest."},{"key":"1111_CR88","volume":"10","author":"MMBL Trinh-Trang-Tan","year":"1999","unstructured":"Trinh-Trang-Tan, M. M. B. L. Upregulation of UT-A2 mRNA by chronic glucagon administration. J. Am. Soc. Nephrol. 10, 25A (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR89","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00424-008-0478-5","volume":"456","author":"Y Yano","year":"2008","unstructured":"Yano, Y., Rodrigues, A. C. Jr., de Braganca, A. C., Andrade, L. C. & Magaldi, A. J. PKC stimulated by glucagon decreases UT-A1 urea transporter expression in rat IMCD. Pflugers Arch. 456, 1229\u20131237 (2008).","journal-title":"Pflugers Arch."},{"key":"1111_CR90","first-page":"F756","volume":"266","author":"T Isozaki","year":"1994","unstructured":"Isozaki, T., Gillin, A. G., Swanson, C. E. & Sands, J. M. Protein restriction sequentially induces new urea transport processes in rat initial IMCD. Am. J. Physiol. 266, F756\u2013F761 (1994).","journal-title":"Am. J. Physiol."},{"key":"1111_CR91","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/MNH.0b013e328349b8f9","volume":"20","author":"KS Kamel","year":"2011","unstructured":"Kamel, K. S. & Halperin, M. L. Intrarenal urea recycling leads to a higher rate of renal excretion of potassium: an hypothesis with clinical implications. Curr. Opin. Nephrol. Hypertens. 20, 547\u2013554 (2011).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"1111_CR92","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13661","volume":"6","author":"L Bankir","year":"2018","unstructured":"Bankir, L. et al. Renal potassium handling in carriers of the Gly40Ser mutation of the glucagon receptor suggests a role for glucagon in potassium homeostasis. Physiol. Rep. 6, e13661 (2018).","journal-title":"Physiol. Rep."},{"key":"1111_CR93","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrendo.2017.80","volume":"13","author":"MC Petersen","year":"2017","unstructured":"Petersen, M. C., Vatner, D. F. & Shulman, G. I. Regulation of hepatic glucose metabolism in health and disease. Nat. Rev. Endocrinol. 13, 572\u2013587 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1111_CR94","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","volume":"9","author":"M Benedict","year":"2017","unstructured":"Benedict, M. & Zhang, X. Non-alcoholic fatty liver disease: an expanded review. World J. Hepatol. 9, 715\u2013732 (2017).","journal-title":"World J. Hepatol."},{"key":"1111_CR95","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","volume":"36","author":"T Bo","year":"2024","unstructured":"Bo, T. et al. Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease. Cell Metab. 36, 947\u2013968 (2024).","journal-title":"Cell Metab."},{"key":"1111_CR96","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrgastro.2013.99","volume":"10","author":"RF Butterworth","year":"2013","unstructured":"Butterworth, R. F. The liver\u2013brain axis in liver failure: neuroinflammation and encephalopathy. Nat. Rev. Gastroenterol. Hepatol. 10, 522\u2013528 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1111_CR97","first-page":"786","volume":"314","author":"SW Brusilow","year":"1986","unstructured":"Brusilow, S. W. & Traystman, R. Hepatic encephalopathy. N. Engl. J. Med. 314, 786\u2013787 (1986). author reply 787.","journal-title":"N. Engl. J. Med."},{"key":"1111_CR98","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cgh.2011.08.028","volume":"10","author":"AJ Montano-Loza","year":"2012","unstructured":"Montano-Loza, A. J. et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin. Gastroenterol. Hepatol. 10, 166\u2013173.e1 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1111_CR99","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.2337\/db23-0858","volume":"73","author":"SAS Kjeldsen","year":"2024","unstructured":"Kjeldsen, S. A. S. et al. Glucagon resistance in individuals with obesity and hepatic steatosis can be measured using the GLUSENTIC test and index. Diabetes 73, 1716\u20131727 (2024).","journal-title":"Diabetes"},{"key":"1111_CR100","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1248\/bpb.b15-00244","volume":"38","author":"Y-S Jung","year":"2015","unstructured":"Jung, Y.-S. Metabolism of sulfur-containing amino acids in the liver: a link between hepatic injury and recovery. Biol. Pharm. Bull. 38, 971\u2013974 (2015).","journal-title":"Biol. Pharm. Bull."},{"key":"1111_CR101","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/archinte.1979.03630480019010","volume":"139","author":"RE Heinig","year":"1979","unstructured":"Heinig, R. E., Clarke, E. F. & Waterhouse, C. Lactic acidosis and liver disease. Arch. Intern. Med. 139, 1229\u20131232 (1979).","journal-title":"Arch. Intern. Med."},{"key":"1111_CR102","first-page":"F947","volume":"252","author":"DE Atkinson","year":"1987","unstructured":"Atkinson, D. E. & Bourke, E. Metabolic aspects of the regulation of systemic pH. Am. J. Physiol. 252, F947\u2013F956 (1987).","journal-title":"Am. J. Physiol."},{"key":"1111_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150440","volume":"11","author":"G Helling","year":"2016","unstructured":"Helling, G. et al. Plasma glutamine concentrations in liver failure. PLoS ONE 11, e0150440 (2016).","journal-title":"PLoS ONE"},{"key":"1111_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1058101","volume":"13","author":"TC Delgado","year":"2022","unstructured":"Delgado, T. C., de las Heras, J. & Mart\u00ednez-Chantar, M. L. Understanding gut-liver axis nitrogen metabolism in fatty liver disease. Front. Endocrinol. 13, 1058101 (2022).","journal-title":"Front. Endocrinol."},{"key":"1111_CR105","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF01649081","volume":"68","author":"D H\u00e4ussinger","year":"1990","unstructured":"H\u00e4ussinger, D., Steeb, R. & Gerok, W. Ammonium and bicarbonate homeostasis in chronic liver disease. Klin. Wochenschr. 68, 175\u2013182 (1990).","journal-title":"Klin. Wochenschr."},{"key":"1111_CR106","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1681\/ASN.2021050680","volume":"33","author":"T Verissimo","year":"2022","unstructured":"Verissimo, T. et al. Decreased renal gluconeogenesis is a hallmark of chronic kidney disease. J. Am. Soc. Nephrol. 33, 810\u2013827 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR107","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.168825","volume":"9","author":"M Darshi","year":"2024","unstructured":"Darshi, M. et al. Glycolytic lactate in diabetic kidney disease. JCI Insight 9, e168825 (2024).","journal-title":"JCI Insight"},{"key":"1111_CR108","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.kint.2023.08.006","volume":"104","author":"K Azushima","year":"2023","unstructured":"Azushima, K. et al. Abnormal lactate metabolism is linked to albuminuria and kidney injury in diabetic nephropathy. Kidney Int. 104, 1135\u20131149 (2023).","journal-title":"Kidney Int."},{"key":"1111_CR109","doi-asserted-by":"publisher","first-page":"F532","DOI":"10.1152\/ajprenal.00038.2023","volume":"324","author":"T Verissimo","year":"2023","unstructured":"Verissimo, T. et al. PCK1 is a key regulator of metabolic and mitochondrial functions in renal tubular cells. Am. J. Physiol. Renal Physiol 324, F532\u2013F543 (2023).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR110","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1681\/ASN.0000000000000156","volume":"34","author":"K Hasegawa","year":"2023","unstructured":"Hasegawa, K., Sakamaki, Y., Tamaki, M. & Wakino, S. PCK1 protects against mitoribosomal defects in diabetic nephropathy in mouse models. J. Am. Soc. Nephrol. 34, 1343\u20131365 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.809485","volume":"9","author":"I San-Millan","year":"2022","unstructured":"San-Millan, I. et al. Chronic lactate exposure decreases mitochondrial function by inhibition of fatty acid uptake and cardiolipin alterations in neonatal rat cardiomyocytes. Front. Nutr. 9, 809485 (2022).","journal-title":"Front. Nutr."},{"key":"1111_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04085-w","volume":"12","author":"Q Yuan","year":"2021","unstructured":"Yuan, Q. et al. CPT1\u03b1 maintains phenotype of tubules via mitochondrial respiration during kidney injury and repair. Cell Death Dis. 12, 792 (2021).","journal-title":"Cell Death Dis."},{"key":"1111_CR113","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000772","author":"CP Kovesdy","year":"2025","unstructured":"Kovesdy, C. P. et al. Dietary protein intake recommendations for patients with non-dialysis dependent CKD: what should healthcare providers do? Clin. J. Am. Soc. Nephrol. https:\/\/doi.org\/10.2215\/CJN.0000000772 (2025).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1111_CR114","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1681\/ASN.2019070677","volume":"31","author":"DE Wesson","year":"2020","unstructured":"Wesson, D. E., Buysse, J. M. & Bushinsky, D. A. Mechanisms of metabolic acidosis-induced kidney injury in chronic kidney disease. J. Am. Soc. Nephrol. 31, 469\u2013482 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR115","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1097\/01.ASN.0000127865.26968.36","volume":"15","author":"G Garibotto","year":"2004","unstructured":"Garibotto, G. et al. Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis. J. Am. Soc. Nephrol. 15, 1606\u20131615 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR116","doi-asserted-by":"publisher","first-page":"696","DOI":"10.34067\/KID.0000000743","volume":"6","author":"ACM Johnson","year":"2025","unstructured":"Johnson, A. C. M. & Zager, R. A. Veverimer, a nonabsorbed gastrointestinal tract HCl binder, decreases renal ammoniagenesis and mitigates nephrotoxic serum nephritis. Kidney360 6, 696\u2013706 (2025).","journal-title":"Kidney360"},{"key":"1111_CR117","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1172\/JCI112020","volume":"76","author":"KA Nath","year":"1985","unstructured":"Nath, K. A., Hostetter, M. K. & Hostetter, T. H. Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J. Clin. Invest. 76, 667\u2013675 (1985).","journal-title":"J. Clin. Invest."},{"key":"1111_CR118","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ki.2015.52","volume":"88","author":"M Vallet","year":"2015","unstructured":"Vallet, M. et al. Urinary ammonia and long-term outcomes in chronic kidney disease. Kidney Int. 88, 137\u2013145 (2015).","journal-title":"Kidney Int."},{"key":"1111_CR119","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2337\/db23-0457","volume":"73","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Effect of dapagliflozin on renal and hepatic glucose kinetics in T2D and NGT subjects. Diabetes 73, 896\u2013902 (2024).","journal-title":"Diabetes"},{"key":"1111_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-025-01879-3","volume":"25","author":"A Di Vincenzo","year":"2025","unstructured":"Di Vincenzo, A. et al. The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob\/ob mice. BMC Endocr. Disord. 25, 63 (2025).","journal-title":"BMC Endocr. Disord."},{"key":"1111_CR121","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.diabet.2018.06.005","volume":"44","author":"C Saponaro","year":"2018","unstructured":"Saponaro, C., Pattou, F. & Bonner, C. SGLT2 inhibition and glucagon secretion in humans. Diabetes Metab. 44, 383\u2013385 (2018).","journal-title":"Diabetes Metab."},{"key":"1111_CR122","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00125-016-3956-x","volume":"59","author":"N Sattar","year":"2016","unstructured":"Sattar, N., McLaren, J., Kristensen, S. L., Preiss, D. & McMurray, J. J. SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia 59, 1333\u20131339 (2016).","journal-title":"Diabetologia"},{"key":"1111_CR123","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2337\/dc18-0165","volume":"41","author":"MS Kuchay","year":"2018","unstructured":"Kuchay, M. S. et al. Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT Trial). Diabetes Care 41, 1801\u20131808 (2018).","journal-title":"Diabetes Care"},{"key":"1111_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1706838","volume":"16","author":"M Sakamoto","year":"2025","unstructured":"Sakamoto, M. et al. Sodium-glucose cotransporter 2 inhibitors \u2014 but not insulin \u2014 enhance renal branched-chain amino acid catabolism. Front. Endocrinol. 16, 1706838 (2025).","journal-title":"Front. Endocrinol."},{"key":"1111_CR125","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1007\/s00125-020-05254-w","volume":"63","author":"G Daniele","year":"2020","unstructured":"Daniele, G. et al. Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy. Diabetologia 63, 2423\u20132433 (2020).","journal-title":"Diabetologia"},{"key":"1111_CR126","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00424-020-02361-w","volume":"472","author":"V Vallon","year":"2020","unstructured":"Vallon, V. Glucose transporters in the kidney in health and disease. Pflugers Arch. 472, 1345\u20131370 (2020).","journal-title":"Pflugers Arch."},{"key":"1111_CR127","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.123.065517","volume":"149","author":"AM Billing","year":"2024","unstructured":"Billing, A. M. et al. Metabolic communication by SGLT2 inhibition. Circulation 149, 860\u2013884 (2024).","journal-title":"Circulation"},{"key":"1111_CR128","doi-asserted-by":"publisher","first-page":"F712","DOI":"10.1152\/ajprenal.00264.2020","volume":"319","author":"A Onishi","year":"2020","unstructured":"Onishi, A. et al. A role for tubular Na+\/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin. Am. J. Physiol. Renal Physiol 319, F712\u2013F728 (2020).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR129","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1681\/ASN.2020071029","volume":"32","author":"FA Borges-Junior","year":"2021","unstructured":"Borges-Junior, F. A. et al. Empagliflozin inhibits proximal tubule NHE3 activity, preserves GFR, and restores euvolemia in nondiabetic rats with induced heart failure. J. Am. Soc. Nephrol. 32, 1616\u20131629 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR130","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1681\/ASN.0000000000000269","volume":"35","author":"VS Rao","year":"2024","unstructured":"Rao, V. S. et al. Empagliflozin in heart failure: regional nephron sodium handling effects. J. Am. Soc. Nephrol. 35, 189\u2013201 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1111_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101934","volume":"84","author":"R Hatano","year":"2024","unstructured":"Hatano, R. et al. Hepatic ketone body regulation of renal gluconeogenesis. Mol. Metab. 84, 101934 (2024).","journal-title":"Mol. Metab."},{"key":"1111_CR132","doi-asserted-by":"publisher","first-page":"F173","DOI":"10.1152\/ajprenal.00462.2018","volume":"316","author":"A Novikov","year":"2019","unstructured":"Novikov, A. et al. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1. Am. J. Physiol. Renal Physiol 316, F173\u2013F185 (2019).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR133","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2215\/CJN.11480821","volume":"17","author":"D Suijk","year":"2022","unstructured":"Suijk, D. et al. SGLT2 inhibition and uric acid excretion in patients with type 2 diabetes and normal kidney function. Clin. J. Am. Soc. Nephrol. 17, 663\u2013671 (2022).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1111_CR134","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/ajh\/hpae092","volume":"37","author":"V Vallon","year":"2024","unstructured":"Vallon, V. State-of-the-Art-Review: mechanisms of action of SGLT2 inhibitors and clinical implications. Am. J. Hypertens. 37, 841\u2013852 (2024).","journal-title":"Am. J. Hypertens."},{"key":"1111_CR135","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/S0140-6736(18)30726-8","volume":"391","author":"P Ambery","year":"2018","unstructured":"Ambery, P. et al. MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study. Lancet 391, 2607\u20132618 (2018).","journal-title":"Lancet"},{"key":"1111_CR136","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/dom.13494","volume":"21","author":"J Tillner","year":"2019","unstructured":"Tillner, J. et al. A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: results of randomized, placebo-controlled first-in-human and first-in-patient trials. Diabetes Obes. Metab. 21, 120\u2013128 (2019).","journal-title":"Diabetes Obes. Metab."},{"key":"1111_CR137","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/dom.14712","volume":"24","author":"VER Parker","year":"2022","unstructured":"Parker, V. E. R. et al. Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease. Diabetes Obes. Metab. 24, 1360\u20131369 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"1111_CR138","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/hep.1840190109","volume":"19","author":"O Hamberg","year":"1994","unstructured":"Hamberg, O. & Vilstrup, H. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon. Hepatology 19, 45\u201354 (1994).","journal-title":"Hepatology"},{"key":"1111_CR139","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2337\/db24-0305","volume":"73","author":"MFG Grondahl","year":"2024","unstructured":"Grondahl, M. F. G. et al. Glucagon clearance is decreased in chronic kidney disease but preserved in liver cirrhosis. Diabetes 73, 1641\u20131647 (2024).","journal-title":"Diabetes"},{"key":"1111_CR140","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/js.2018-00321","volume":"3","author":"JJ Liu","year":"2019","unstructured":"Liu, J. J. et al. Relationship between fasting plasma glucagon level and renal function \u2014 a cross-sectional study in individuals with type 2 diabetes. J. Endocr. Soc. 3, 273\u2013283 (2019).","journal-title":"J. Endocr. Soc."},{"key":"1111_CR141","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ndt\/gfx039","volume":"33","author":"R Vanholder","year":"2018","unstructured":"Vanholder, R., Gryp, T. & Glorieux, G. Urea and chronic kidney disease: the comeback of the century? (in uraemia research). Nephrol. Dial. Transpl. 33, 4\u201312 (2018).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1111_CR142","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/BF00583277","volume":"403","author":"C Bailly","year":"1985","unstructured":"Bailly, C., Roinel, N. & Amiel, C. Stimulation by glucagon and PTH of Ca and Mg reabsorption in the superficial distal tubule of the rat kidney. Pflugers Arch. 403, 28\u201334 (1985).","journal-title":"Pflugers Arch."},{"key":"1111_CR143","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2020.06.045","volume":"182","author":"MH Chen","year":"2020","unstructured":"Chen, M. H. et al. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell 182, 1198\u20131213.e14 (2020).","journal-title":"Cell"},{"key":"1111_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156057","volume":"161","author":"K Stefanakis","year":"2024","unstructured":"Stefanakis, K., Kokkorakis, M. & Mantzoros, C. S. The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation. Metabolism 161, 156057 (2024).","journal-title":"Metabolism"},{"key":"1111_CR145","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.2001.20764","volume":"37","author":"SR Price","year":"2001","unstructured":"Price, S. R., Du, J. D., Bailey, J. L. & Mitch, W. E. Molecular mechanisms regulating protein turnover in muscle. Am. J. Kidney Dis. 37, S112\u2013S114 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"1111_CR146","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0026-0495(98)90036-1","volume":"47","author":"A Battezzati","year":"1998","unstructured":"Battezzati, A., Simonson, D. C., Luzi, L. & Matthews, D. E. Glucagon increases glutamine uptake without affecting glutamine release in humans. Metabolism 47, 713\u2013723 (1998).","journal-title":"Metabolism"},{"key":"1111_CR147","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.clnesp.2024.05.023","volume":"62","author":"M Negro","year":"2024","unstructured":"Negro, M., Crisafulli, O. & D\u2019Antona, G. Effects of essential amino acid (EAA) and glutamine supplementation on skeletal muscle wasting in acute, subacute, and postacute conditions. Clin. Nutr. ESPEN 62, 224\u2013233 (2024).","journal-title":"Clin. Nutr. ESPEN"},{"key":"1111_CR148","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/jcsm.12434","volume":"10","author":"Y Hong","year":"2019","unstructured":"Hong, Y., Lee, J. H., Jeong, K. W., Choi, C. S. & Jun, H. S. Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy. J. Cachexia Sarcopenia Muscle 10, 903\u2013918 (2019).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1111_CR149","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2215\/CJN.0000000000000487","volume":"19","author":"TY Yang","year":"2024","unstructured":"Yang, T. Y. et al. Sodium bicarbonate treatment and clinical outcomes in chronic kidney disease with metabolic acidosis: a meta-analysis. Clin. J. Am. Soc. Nephrol. 19, 959\u2013969 (2024).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1111_CR150","doi-asserted-by":"publisher","first-page":"F712","DOI":"10.1152\/ajprenal.00088.2024","volume":"327","author":"AB Bomholt","year":"2024","unstructured":"Bomholt, A. B. et al. Glucagon receptor activation contributes to the development of kidney injury. Am. J. Physiol. Renal Physiol 327, F712\u2013F724 (2024).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1111_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63529-5","volume":"16","author":"X Liu","year":"2025","unstructured":"Liu, X. et al. Prolonged glucagon exposure rewires lipid oxidation and drives diabetic kidney disease progression. Nat. Commun. 16, 8561 (2025).","journal-title":"Nat. Commun."},{"key":"1111_CR152","doi-asserted-by":"publisher","unstructured":"Kanoo, S. et al. Glucagon receptor agonist aggravates a murine model of Balkan nephropathy. Am. J. Physiol. Renal Physiol. https:\/\/doi.org\/10.1152\/ajprenal.00160.2026 (2026).","DOI":"10.1152\/ajprenal.00160.2026"},{"key":"1111_CR153","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/BF00280519","volume":"19","author":"HH Parving","year":"1980","unstructured":"Parving, H. H., Christiansen, J. S., Noer, I., Tronier, B. & Mogensen, C. E. The effect of glucagon infusion on kidney function in short-term insulin-dependent juvenile diabetics. Diabetologia 19, 350\u2013354 (1980).","journal-title":"Diabetologia"},{"key":"1111_CR154","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","volume":"16","author":"V Vallon","year":"2020","unstructured":"Vallon, V. & Thomson, S. C. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat. Rev. Nephrol. 16, 317\u2013336 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"1111_CR155","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.kint.2024.08.023","volume":"106","author":"V Selvarajah","year":"2024","unstructured":"Selvarajah, V. et al. A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease. Kidney Int. 106, 1170\u20131180 (2024).","journal-title":"Kidney Int."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01111-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:38:52Z","timestamp":1792096732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01111-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":155,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1111"],"URL":"https:\/\/doi.org\/10.1038\/s41581-026-01111-y","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"20 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Over the past 36 months, V.V. has served as a consultant and received honoraria from AstraZeneca, Boehringer Ingelheim, Casdin Capital, Checkpointlp, GondolaBridge and Google Venture, and received grant support for investigator-initiated research from Boehringer Ingelheim, Jnana Therapeutics, Lexicon, Merck, Maze Therapeutics and Novo Nordisk. N.J.W.A. has received research support, personal fees and speaker fees from EvoSep, Mercodia, Novo Nordisk, Merck\/MSD, Roche and Boehringer Ingelheim.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}